English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/165541
COMPARTIR / IMPACTO:
Estadísticas
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Título

Highly efficient neural conversion of human pluripotent stem cells in adherent and animal-free conditions

AutorLukovic, Dunja ; Díez-Lloret, Andrea ; Stojkovic, Petra; Rodríguez Martínez, Daniel ; Rodríguez-Jiménez, Francisco Javier; González-Rodríguez, P.; López-Barneo, José ; Moreno-Manzano, Victoria; Stojkovic, Miodrag; Bhattacharya, Shom Shanker ; Erceg, Slaven
Palabras claveClinical translation
Cellular therapy
Pluripotent stem cells
Neural differentiation
Induced pluripotent stem cells
Embryonic stem cells
Differentiation
Fecha de publicación2017
EditorWiley-Blackwell
AlphaMed Press
CitaciónStem Cells 6(4): 1217-1226 (2017)
ResumenNeural differentiation of human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) can produce a valuable and robust source of human neural cell subtypes, holding great promise for the study of neurogenesis and development, and for treating neurological diseases. However, current hESCs and hiPSCs neural differentiation protocols require either animal factors or embryoid body formation, which decreases efficiency and yield, and strongly limits medical applications. Here we develop a simple, animal-free protocol for neural conversion of both hESCs and hiPSCs in adherent culture conditions. A simple medium formula including insulin induces the direct conversion of >98% of hESCs and hiPSCs into expandable, transplantable, and functional neural progenitors with neural rosette characteristics. Further differentiation of neural progenitors into dopaminergic and spinal motoneurons as well as astrocytes and oligodendrocytes indicates that these neural progenitors retain responsiveness to instructive cues revealing the robust applicability of the protocol in the treatment of different neurodegenerative diseases. The fact that this protocol includes animal-free medium and human extracellular matrix components avoiding embryoid bodies makes this protocol suitable for the use in clinic.
DescripciónLukovic, Dunja et al.
Versión del editorhttps://doi.org/10.1002/sctm.16-0371
URIhttp://hdl.handle.net/10261/165541
Identificadoresdoi: 10.1002/sctm.16-0371
e-issn: 2157-6580
issn: 2157-6564
Aparece en las colecciones: (IBIS) Artículos
(CABIMER) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
animalfree.pdf760,42 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.